CRISPR THERAPEUTICS AG Common Stock, Capital Shares Reserved for Future Issuance
CRISPR THERAPEUTICS AG (CRSP) had Common Stock, Capital Shares Reserved for Future Issuance of 9.37 million shares as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-03
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 9.37M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 8.20M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 8.20M shares.
- 2022-12-31: Common Stock, Capital Shares Reserved for Future Issuance 5.03M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 9.37M shares 10-Q · filed 2026-08-03 |
| 2026-03-31 | 8.20M shares 10-Q · filed 2026-05-04 |
| 2025-12-31 | 8.20M shares 10-K · filed 2026-02-12 |
| 2022-12-31 | 5.03M shares 10-K · filed 2023-02-21 |
| 2021-12-31 | 5.04M shares 10-K · filed 2022-02-15 |
| 2020-12-31 | 2.91M shares 10-K · filed 2021-02-16 |
| 2019-12-31 | 1.23M shares 10-K · filed 2020-02-12 |
| 2019-09-30 | 230.73K shares 10-Q · filed 2019-10-28 |
| 2019-06-30 | 1.68M shares 10-Q · filed 2019-07-29 |
| 2019-03-31 | 368.42K shares 10-Q · filed 2019-04-29 |
| 2018-09-30 | 19.52M shares 10-Q · filed 2018-11-07 |
| 2018-06-30 | 19.70M shares 10-Q · filed 2018-08-07 |
| 2018-03-31 | 16.11M shares 10-Q · filed 2018-05-08 |
| 2017-12-31 | 16.42M shares 10-Q · filed 2018-11-07 |
| 2017-09-30 | 16.75M shares 10-Q · filed 2017-11-08 |
| 2017-06-30 | 17.08M shares 10-Q · filed 2017-08-10 |
| 2017-03-31 | 15.33M shares 10-Q · filed 2017-05-11 |
| 2016-12-31 | 15.33M shares 10-K · filed 2018-03-08 |
| 2016-09-30 | 38.45M shares 10-Q · filed 2016-11-22 |
| 2015-12-31 | 2.44M shares 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |